In this video:
Sourabh Sobti, Business Development Lead, CEPI

Topic: Investments in vaccine delivery

Key Highlights:
1) Create vaccine libraries against representative pathogens from virus families with greatest pandemic potential

2) Establish global clinical trials and laboratory networks with pre-established processes and protocols to enable rapid generation of clinical evidence of efficacy and safety of vaccines.

3) Optimise manufacturing processes for rapid initial production and subsequent scaling based on prior scale-up transfer experience with same or similar platforms

4) Monitor global surveillance and lab networks for potential alert triggers

The post Sourabh Sobti, Business Development Lead, CEPI | FDD Conclave 2023 appeared first on Express Pharma.

Panelists in this video:
+ Dr Sunil Tiwari, Sr VP R&D, Hetero Drugs
+ Dr Vaibhav Sihorkar, VP & Head- Developability & Formulations, Sai Life Sciences
+ Dr Sajeev Chandran, VP-R&D, Lupin
+ Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals
+ Dr Abir Banerjee, VP-R&D Biotech, Bharat Serums & Vaccines
+ Dr Khalid Akhter Ansari, Group Head, Formulation Development, Oral solid and Parenteral Dosage Forms, Novartis

Moderator:
+ Dr Rakesh Bhasin, VP-Formulations, Biocon

Key Highlights:
1) Dr Rakesh Bhasin, VP-Formulations, Biocon:
+ Evolution platform from conventional technology to controlled drug delivery to device driven delivery has now reached stage of target delivery

2) Dr Sunil Tiwari, Sr VP R&D, Hetero Drugs:
+ Patient centricity and compliance are crucial for faster and meaningful evolution

3) Dr Vaibhav Sihorkar, VP & Head- Developability & Formulations, Sai Life Sciences:
+ We need strategies and approaches to eliminate complexities in drug delivery

4) Dr Sajeev Chandran, VP-R&D, Lupin:
+ Innovation in drug delivery needs to be driven by patient centric therapeutic adherence tools that are market need driven rather than just the technology push driven innovation

5) Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals:
+ Scaling up the R&D to production level is important

6) Dr Abir Banerjee, VP-R&D Biotech, Bharat Serums and Vaccines:
+ We should focus on skilling upcoming researchers with case studies for more meaning innovations

The post Panel Discussion: Evolutions and revolutions in drug delivery | FDD Conclave 2023 appeared first on Express Pharma.

FDD Leadership Awards 2023 Winners:

Award Category: Rising Stars
+ Dr Ajay Singh
+ Dr Khalid Akhter Ansari
+ Dr Prigneshkumar Patel
+ Mr Rajesh Rao
+ Mr Samarth Kumar
+ Mr Vijay Kumar Kuvar

Award Category: Leaders
+ Dr H B Pushpalatha
+ Mr Manikandan Ramalingam
+ Mr Prasanna Kumar J
+ Ms Preeti Raut
+ Dr Rajender Burki

Award Category: Stalwarts
+ Dr Kishore Deo
+ Mr Makarand Avachat
+ Dr Ravikumar N
+ Mr Subhrangshu Sengupta

The post FDD Leadership Awards 2023 | FDD Conclave 2023 appeared first on Express Pharma.

In this video:
Vaibhav Datke, Sr Manager – Business Development, Ami Polymer

Topic: Polymer solutions to pharmaceutical industry

Key Highlights:
1) Low hysteresis grade of platinum silicone results less heat build up and provides excellent flex crack resistance

2) Imaliner tubing are specially formulated inner layer for preservatives resistance

3) FEP/PTFE tubing is compatible with all corrosive solvents

The post Vaibhav Datke, Sr Manager – Business Development, Ami Polymer | FDD Conclave 2023 appeared first on Express Pharma.

In this video:
Manisha Chaudhari, Senior Technical Application Expert, Merck Lifescience, India

Topic: Addressing pharmaceutical & biological product development challenges with innovative excipients

Key Highlights:
1) Predictive formulation promises to increase speed, reduce cost and create better outcomes in drug development

2) In the first wave, our focus is on enhancing solubility of APIs via crystal engineering and amorphous formulation modules

3) Target is to launch first predictive formulation product, based on crystal engineering in 2024

The post Manisha Chaudhari, Senior Technical Application Expert, Merck Lifescience, India | FDD Conclave 2023 appeared first on Express Pharma.

Panelists in this video:
+ Dr Ajay Singh, Head – mRNA Department, Gennova Biopharmaceuticals
+ Dr Rajender Burki, Associate VP, R&D, Biological E
+ Dr Tarun Sharma, Sr VP R&D, Auro Vaccines
+ Dr Rajendra Lingala, VP & Head R&D, Indian Immunologicals

Moderator:
+ Dr Ramesh Matur, Sr VP, Head R&D, Biological E

Key Highlights:
1) Dr Ramesh Matur, Sr VP, Head R&D, Biological E:
+ Formulation development of vaccines is different from the formulation development of other drugs. Every vaccine is customised to a disease

2) Dr Ajay Singh, Head – mRNA Department, Gennova Biopharmaceuticals:
+ The way to democratise the mRNA platform lies in stabilisation of the formulation

3) Dr Rajendra Lingala, VP & Head R&D, Indian Immunologicals:
+ Micro needle patches are a more advantageous way of vaccine delivery, even for immuno compromised patients

4) Dr Tarun Sharma, Sr VP R&D, Auro Vaccines:
+ Micro needle patches are an evolving area, especially in commercial manufacturing. Scalability is an issue currently but we will see significant progress in future

5) Dr Rajender Burki, Associate VP, R&D, Biological E:
+ Vaccines development approaches need to generate a response even in the immuno-compromised. For instance, combination vaccines can help reduce intake of aluminium in paediatric vaccines

The post Panel Discussion: Advancements in vaccine development: new-age FR&D techniques and next-gen delivery systems | FDD Conclave 2023 appeared first on Express Pharma.

In this video:
Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities

Topic: Future of lubricants

Key Highlights:
1) Customisation of lubricants is need of the hour

2) Sodium Stearyl Fumarate would be the choice of lubricant in future due to its lower impact on tablet attributes

3) Demand for special lubricants for effervescent tablets, clean label lubricants for nutra, environmentally sustainable lubricants and novel lubricants will see growing demand in future

The post Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities | FDD Conclave 2023 appeared first on Express Pharma.

In this video:
WonHyun (James) Hwang, Head of Application, Asia and Middle East of Africa Biopharma, Avantor Performance Materials Korea

Topic: Impact on final formulation by Bakerbond® Chromatography Resin

Key Highlights:
1) Our BAKERBOND chromatography data range and ligand information are provided in regulatory support files along with methods to test

2) Buffer pH & additives can influence product quality and process performance

3) IPC for intermediate product is designated for product purity and pH conductivity

4) OBC and UV cut off are critical process parameters. They have main and interaction effects on drug quality and process performance with process buffers.

The post WonHyun (James) Hwang, Head of Application, Asia and Middle East of Africa Biopharma, Avantor Performance Materials Korea | FDD Conclave 2023 appeared first on Express Pharma.